Milašinović, B.; Vezmar Kovačević, S.; Marković, S.; Jovanović, M.; Knežević Ivanovski, T.; Kralj, Đ.; Svorcan, P.; Miljković, B.; Vučićević, K.
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis. Pharmaceuticals 2025, 18, 1127.
https://doi.org/10.3390/ph18081127
AMA Style
Milašinović B, Vezmar Kovačević S, Marković S, Jovanović M, Knežević Ivanovski T, Kralj Đ, Svorcan P, Miljković B, Vučićević K.
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis. Pharmaceuticals. 2025; 18(8):1127.
https://doi.org/10.3390/ph18081127
Chicago/Turabian Style
Milašinović, Bojana, Sandra Vezmar Kovačević, Srđan Marković, Marija Jovanović, Tamara Knežević Ivanovski, Đorđe Kralj, Petar Svorcan, Branislava Miljković, and Katarina Vučićević.
2025. "Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis" Pharmaceuticals 18, no. 8: 1127.
https://doi.org/10.3390/ph18081127
APA Style
Milašinović, B., Vezmar Kovačević, S., Marković, S., Jovanović, M., Knežević Ivanovski, T., Kralj, Đ., Svorcan, P., Miljković, B., & Vučićević, K.
(2025). Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis. Pharmaceuticals, 18(8), 1127.
https://doi.org/10.3390/ph18081127
